In turn, TLR4 activation in MetS may increase reactive oxygen species production, which has been related to inflammation, endothelial dysfunction, and metabolic impairment (Boutagy et al., 2016; Ali et al., 2021). This evidence concerns the gene TLR4 and metabolic syndrome.